+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Singulair"

Investigation Report on China's Montelukast Market, 2018-2022 - Product Thumbnail Image

Investigation Report on China's Montelukast Market, 2018-2022

  • Report
  • November 2018
  • 30 Pages
  • China
From
Asthma Forecast and Market Analysis to 2024 - Product Thumbnail Image

Asthma Forecast and Market Analysis to 2024

  • Report
  • February 2018
  • 680 Pages
  • Global
From
Drug Overview: Singulair - Product Thumbnail Image

Drug Overview: Singulair

  • Drug Pipelines
  • February 2018
  • 16 Pages
  • Global
From
Singulair Paediatric - API Insight, 2022 - Product Thumbnail Image

Singulair Paediatric - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Singulair Paediatric- Drug Insight, 2019 - Product Thumbnail Image

Singulair Paediatric- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
  • 9 Results (Page 1 of 1)
Loading Indicator

Singulair is a prescription medication used to treat asthma and allergies. It is a leukotriene receptor antagonist, which works by blocking the action of leukotrienes, a type of chemical that can cause inflammation in the lungs. Singulair is also used to prevent exercise-induced bronchoconstriction, a narrowing of the airways that can occur during physical activity. It is available in tablet, chewable tablet, and granule form. Singulair is part of a larger class of respiratory drugs known as bronchodilators, which are used to treat asthma and other respiratory conditions. Other bronchodilators include albuterol, ipratropium, and theophylline. These drugs work by relaxing the muscles in the airways, allowing air to flow more freely. Singulair is a popular choice for treating asthma and allergies, as it is effective and has few side effects. It is also used to treat chronic obstructive pulmonary disease (COPD) and other respiratory conditions. Companies in the Singulair market include Merck & Co., Inc., Teva Pharmaceuticals, and Mylan N.V. Show Less Read more